Head to Head Survey: Oramed Pharmaceuticals (NASDAQ:ORMP) vs. Structure Therapeutics (NASDAQ:GPCR)
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) and Structure Therapeutics (NASDAQ:GPCR – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 5.8% of Oramed Pharmaceuticals […]
More Stories
Advisors Asset Management Inc. Makes New Investment in Cencora, Inc. (NYSE:COR)
Advisors Asset Management Inc. bought a new stake in Cencora, Inc. (NYSE:COR – Free Report) during the 1st quarter, according...
Hydro One (TSE:H) Hits New 1-Year High at $42.03
Shares of Hydro One Limited (TSE:H – Get Free Report) reached a new 52-week high on Wednesday . The company...
Advisors Asset Management Inc. Increases Stock Holdings in Herc Holdings Inc. (NYSE:HRI)
Advisors Asset Management Inc. lifted its position in Herc Holdings Inc. (NYSE:HRI – Free Report) by 9.2% in the first...
Advisors Asset Management Inc. Decreases Position in Principal Financial Group, Inc. (NYSE:PFG)
Advisors Asset Management Inc. lowered its stake in shares of Principal Financial Group, Inc. (NYSE:PFG – Free Report) by 12.2%...
Shell Asset Management Co. Buys 7,728 Shares of General Motors (NYSE:GM)
Shell Asset Management Co. lifted its position in General Motors (NYSE:GM – Free Report) (TSE:GMM.U) by 27.5% during the first...
Emergent BioSolutions (NYSE:EBS) Reaches New 52-Week High at $13.23
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) reached a new 52-week high on Wednesday . The company...